Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan impact on oxidative stress and C-reactive protein in persistent atrial fibrillation
2007-003262-17Phase 4Terminated
- Sponsor
- University Hospital Magdeburg
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Atrial fibrillation (AFib) comparing Irbesartan with Placebo (2 arms). Primary endpoint: Reduction of oxidative stress markers and adhesion molecules. Started Jul 2008; status: terminated.
02
Drugs
irbesartan
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2007-003262-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003262-17.